Kew Gardens, New York Clinical Trials

A listing of Kew Gardens, New York clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 544 clinical trials
ExAblate Blood-Brain Barrier (BBB) Disruption for the Treatment of Alzheimer's Disease

The purpose of this study is to evaluate the safety and efficacy of the ExAblate Model 4000 Type 2.0 System as a tool to disrupt the blood-brain barrier (BBB) in patients with probable Alzheimer's Disease (AD).

alzheimer's disease
Weill Cornell Medicine
 (8.0 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +2 other locations
CW Non-featured Trials

Test non-featured trials

Site1
 (8.2 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • 1 location
PRAGMA (Prostate Radio Ablation Guided by Magnetic Resonance Imaging Acquisition) in Metastatic Prostate Cancer

Patients with metastatic prostate cancer can undergo MRI-guided prostate Stereotactic body radiation therapy (SBRT) without significant adverse events, similar to what has been reported for patients with localized prostate cancer. We hypothesize that prostate SBRT will be well-tolerated in metastatic prostate cancer patients, with quality of life outcomes similar to …

adenocarcinoma of prostate
MRI
non-metastatic prostate cancer
metastatic prostate cancer
adenocarcinoma
Weill Cornell Medicine
 (8.0 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • 1 location
A Study of the Use of Text Message Reminders to Take Palbociclib

The purpose of this study is to find out whether it is feasible (acceptable to participants) to use a smartphone app to send text message reminders to take palbociclib, and whether these reminders are effective at helping people remember to take palbociclib according to the treatment schedule.

cancer diagnosis
faslodex
treatment regimen
fulvestrant
breast carcinoma
Memorial Sloan Kettering Cancer Center
 (8.0 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • 1 location
CIMER: Combined Immunotherapies in Metastatic ER+ Breast Cancer

Women with Hormone Receptor (HR)+ Human Epidermal growth factor Receptor (HER)2- metastatic breast cancer are eligible to a randomized trial. Patients receiving standard first line therapy for metastatic HR+ Breast cancer(BC) (letrozole+palbociclib) are randomly assigned to also receive Stereotactic Body Radiation Therapy(SBRT) to each metastatic lesion.

conjugated bilirubin
stage iv breast cancer
anticoagulant therapy
neutrophil count
direct bilirubin
Weill Cornell Medicine
 (8.0 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • 1 location
GNOS-PV02 Personalized Neoantigen Vaccine INO-9012 and Pembrolizumab in Subjects With Advanced HCC

This is a single-arm, open-label, multi-site Phase I/IIa study of a personalized neoantigen DNA vaccine (GNOS-PV02) and plasmid encoded IL-12 (INO-9012) in combination with pembrolizumab (MK-3475) in subjects with histologically or cytologically confirmed diagnosis of HCC based on pathology report.

lenvatinib
measurable disease
pembrolizumab
liver cancer
chronic infection
Icahn School of Medicine at Mount Sinai
 (8.4 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +2 other locations
Diffusion MRI for Head and Neck Cancer

The proposed study is to investigate the feasibility of using quantitative diffusion MRI (dMRI) methods for accurate and comprehensive assessment of treatment response. dMRI is a powerful tool to probe treatment-induced change in tumors. It is a unique in vivo imaging technique sensitive to cellular microstructures at the scale of …

chemoradiation therapy
chemoradiotherapy
neck cancer
cancer
probe
NYU Langone
 (8.3 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • 1 location
Hypofractionated Radiotherapy in Elderly Patients With Head & Neck Squamous Cell Carcinoma

The purpose of this research study is to investigate a shorter radiation treatment schedule for head and neck cancers in patients 70 years of age and older. Standard radiation treatment for head and neck patients normally requires that the patient travel to the hospital daily for 6-7 weeks to receive …

Mount Sinai Downtown Union Square
 (8.4 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +3 other locations
A Study of LY3819253 (LY-CoV555) in Participants Hospitalized for COVID-19

The purpose of this study is to test the safety and tolerability of LY3819253 when it is given by injection into a vein to participants hospitalized with COVID-19. Blood tests will be done to check how much LY3819253 is in the bloodstream and how long the body takes to eliminate …

blood test
covid-19
Alexandria Center for Life - NYC/ NYCEDC
 (8.3 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +10 other locations
Acalabrutinib Study With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19.

CALAVI US will investigate the safety, efficacy and pharmacokinetics of acalabrutinib together with Best Supportive Care in the treatment of COVID-19.

pneumonia
acalabrutinib
SARS
acute respiratory syndrome (sars)
covid-19
Research Site
 (8.0 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +9 other locations